Nels P. Bergmark
Comptroller/Controller/Auditor bei Ash Access Technology, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Robert Truitt | M | - |
Ash Access Technology, Inc.
 Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 41 Jahre |
| Stephen R. Ash | M | 78 |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 41 Jahre |
| Norman R. Weldon | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Gary Lehman | M | 71 |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Lorelei D. Davis | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Daniel J. Olson | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 19 Jahre |
| Joseph H. Broecker | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Adel B. Korkor | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Domenick P. Treschitta | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| William J. Parsons | M | - |
Western Michigan University
| 6 Jahre |
| Thomas Terwilliger | M | - |
Western Michigan University
| 5 Jahre |
| Jay Allen Fishman | M | 79 |
Western Michigan University
| 5 Jahre |
| Kenneth L. Taft | M | - |
Western Michigan University
| 6 Jahre |
| Jim Mehling | M | - |
Western Michigan University
| 4 Jahre |
| Abdulwahab Al-Wazzan | M | - |
Western Michigan University
| 4 Jahre |
| Marti Smith | F | - |
Western Michigan University
| 4 Jahre |
| James William Beeke | M | 74 |
Western Michigan University
| 4 Jahre |
| Mike Moshier | M | - |
Western Michigan University
| 4 Jahre |
| Roland K. Winger | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Alvaro F. Guillem | M | 67 |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 3 Jahre |
| Dick Rhodes | M | - |
Western Michigan University
| 4 Jahre |
| Robert J. McNulty | M | 77 |
Western Michigan University
| 2 Jahre |
| Steven Quay | M | 73 |
Western Michigan University
| 4 Jahre |
| Thomas L. Robyn | M | 83 |
Western Michigan University
| 4 Jahre |
| Thomas Seavey | M | 77 |
Western Michigan University
| 4 Jahre |
| Kenneth P. Nobis | M | - |
Western Michigan University
| 4 Jahre |
| Art Zaske | M | 76 |
Western Michigan University
| 4 Jahre |
| Michael R. Kargula | M | - |
Western Michigan University
| 4 Jahre |
| Joseph Harenza | M | 79 |
Western Michigan University
| 4 Jahre |
| Rolf Ruhfus | M | 79 |
Western Michigan University
| 4 Jahre |
| Timothy Hoeksema | M | 77 |
Western Michigan University
| 4 Jahre |
| Philip Y. Shen | M | 79 |
Western Michigan University
| 3 Jahre |
| Carmine J. Durham | M | - |
Ash Access Technology, Inc.
Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
| Robert Herr | M | 78 |
Western Michigan University
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 34 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Nels P. Bergmark
- Persönliches Netzwerk
